Literature DB >> 14993313

Identification of a topoisomerase IV in actinobacteria: purification and characterization of ParYR and GyrBR from the coumermycin A1 producer Streptomyces rishiriensis DSM 40489.

Elisabeth Schmutz1, Susanne Hennig, Shu-Ming Li, Lutz Heide.   

Abstract

The biosynthetic gene clusters of the gyrase inhibitors coumermycin A(1) and clorobiocin contain two different resistance genes (gyrB(R) and parY(R)). Both genes code for B subunits of type II topoisomerases. The authors have now overexpressed and purified the encoded proteins, as well as the corresponding A subunits GyrA and ParX. Expression was carried out in Streptomyces lividans in the form of hexahistidine fusion proteins, allowing purification by nickel affinity chromatography. The complex of GyrA and GyrB(R) was found to catalyse ATP-dependent supercoiling of DNA, i.e. to function as a gyrase, whereas the complex of ParX and ParY(R) catalysed ATP-dependent decatenation and relaxation, i.e. the functions of topoisomerase IV (topo IV). This is believed to represent the first topo IV identified in the class of actinobacteria, and the first demonstration of the formation of a topo IV as a resistance mechanism of an antibiotic producer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14993313     DOI: 10.1099/mic.0.26867-0

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  10 in total

Review 1.  Avoidance of suicide in antibiotic-producing microbes.

Authors:  Eric Cundliffe; Arnold L Demain
Journal:  J Ind Microbiol Biotechnol       Date:  2010-05-06       Impact factor: 3.346

2.  Role of an FtsK-like protein in genetic stability in Streptomyces coelicolor A3(2).

Authors:  Lei Wang; Yanfei Yu; Xinyi He; Xiufen Zhou; Zixin Deng; Keith F Chater; Meifeng Tao
Journal:  J Bacteriol       Date:  2007-01-05       Impact factor: 3.490

3.  Heterologous expression of novobiocin and clorobiocin biosynthetic gene clusters.

Authors:  Alessandra S Eustáquio; Bertolt Gust; Ute Galm; Shu-Ming Li; Keith F Chater; Lutz Heide
Journal:  Appl Environ Microbiol       Date:  2005-05       Impact factor: 4.792

4.  Genome-Wide Identification of the LexA-Mediated DNA Damage Response in Streptomyces venezuelae.

Authors:  Kathryn J Stratton; Matthew J Bush; Govind Chandra; Clare E M Stevenson; Kim C Findlay; Susan Schlimpert
Journal:  J Bacteriol       Date:  2022-07-13       Impact factor: 3.476

5.  Functional analysis of three topoisomerases that regulate DNA supercoiling levels in Chlamydia.

Authors:  Emilie Orillard; Ming Tan
Journal:  Mol Microbiol       Date:  2015-11-13       Impact factor: 3.501

6.  Simocyclinone D8, an inhibitor of DNA gyrase with a novel mode of action.

Authors:  Ruth H Flatman; Alison J Howells; Lutz Heide; Hans-Peter Fiedler; Anthony Maxwell
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

7.  Structure-activity relationships of aminocoumarin-type gyrase and topoisomerase IV inhibitors obtained by combinatorial biosynthesis.

Authors:  Ruth H Flatman; Alessandra Eustaquio; Shu-Ming Li; Lutz Heide; Anthony Maxwell
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

8.  Topoisomerase IV is required for partitioning of circular chromosomes but not linear chromosomes in Streptomyces.

Authors:  Tzu-Wen Huang; Chin-Chen Hsu; Han-Yu Yang; Carton W Chen
Journal:  Nucleic Acids Res       Date:  2013-09-02       Impact factor: 16.971

9.  Abundant antibiotic resistance genes in rhizobiome of the human edible Moringa oleifera medicinal plant.

Authors:  Ashwag Y Shami; Aala A Abulfaraj; Mohammed Y Refai; Aminah A Barqawi; Najat Binothman; Manal A Tashkandi; Hanadi M Baeissa; Lina Baz; Haneen W Abuauf; Ruba A Ashy; Rewaa S Jalal
Journal:  Front Microbiol       Date:  2022-09-15       Impact factor: 6.064

10.  The role of Ca²⁺ in the activity of Mycobacterium tuberculosis DNA gyrase.

Authors:  Shantanu Karkare; Faridoon Yousafzai; Lesley A Mitchenall; Anthony Maxwell
Journal:  Nucleic Acids Res       Date:  2012-07-27       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.